Persistent Opioid Use High in Head, Neck Cancer Patients
FRIDAY, Jan. 11, 2019 -- Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery.
Jessica D. McDermott, M.D., from the University of Colorado Anschutz School of Medicine in Aurora, and colleagues used data from the Surveillance, Epidemiology and End Results-Medicare database (2008 to 2011) to identify 976 nondistant metastatic oral cavity and oropharynx patients undergoing treatment.
https://www.drugs.com/news/persistent-opioid-head-neck-cancer-patients-79679.htmlThe researchers found that 83.1 percent of patien